Hypothalamically-Induced Insulin Release and its Potentiation During Oral and Intravenous Glucose Loads by Steffens, A.B., et al.
Brain Research, 301 (1984) 351-361  351 
Elsevier 
BRE 10032 
Hypothalamically-Induced Insulin Release and its Potentiation During Oral and 
Intravenous Glucose Loads 
A. B. STEFFENS, G. FLIK, F. KUIPERS, E. C. LO'FrER and P. G. M. LUITEN 
Department of  Animal Physiology,  State University of Groningen, P.O. Box 14, 9750 AA Haren (The Netherlands) 
(Accepted October llth, 1983) 
Key words: rat -- lateral hypothalamus -- endocrine pancreas -- noradrenergic stimulation -- vagus -- glucose -- glucagon -- insulin 
Male Wistar rats were provided with bilateral  cannulas in the lateral hypothalamic area (LHA) and cannulas in the left and right jug- 
ular vein. Freely moving rats provided in this way with cannulas were infused with transmitters in the LHA and with various substances 
in the blood circulation during simultaneous sampling of blood without disturbing the animals. Infusion of norepinephrine (NE) in the 
LHA resulted in increased insulin levels while plasma glucagon and blood glucose were nearly not affected. This LHA mediated insu- 
lin release was suppressed by atropine injection in the blood circulation suggesting a vagal contribution to the observed phenomenon. 
Administration of either an oral or i.v. glucose load during qoradrenergic stimulation of the LHA elicited an exaggerated insulin re- 
sponse when compared to their controls. This LHA potentiated insulin response during an oral and i.v. glucose load could be sup- 
pressed by atropinization of the rats. It is concluded that meal-related stimuli are relayed to the NE-stimulated area of the LHA and 
that these stimuli modulate the output from this area of the LHA that is concerned with the release of insulin. 
INTRODUCTION 
A  large body of evidence has accumulated indicat- 
ing that apart from circulating blood nutrients the au- 
tonomic nervous  system plays an  important  role in 
the regulation of the release of insulin and glucagon 
from the endocrine pancreas6aO,15,17. 
Electrical stimulation of the vagal branches to the 
pancreas elicits insulin release6,15 though vagal stimu- 
lation results in some species (dog and calf) in con- 
comitant glucagon releaseS,17.  Electrical stimulation 
of the  splanchnic nerve,  on  the other hand,  causes 
glucagon release and suppression of insulin release  4. 
Not only electrical stimulation of the vagus and the 
splanchnic nerve but also neurotransmitters involved 
in the action of the peripheral part of the autonomic 
nervous system are capable to influence the islet of 
Langerhans.  Norepinephrine (NE),  the sympathetic 
neurotransmitter and epinephrine (E) released con- 
comitantly with NE by the adrenal medulla influence 
insulin release via direct stimulation of the a- and r- 
receptors of the B  cell of the islets of Langerhans  23. 
Stimulation of the a-receptors inhibits insulin release 
while r-receptor stimulation elicits insulin release  23. 
The  catecholamines  inhibit glucose  induced  insulin 
release19,  23. The B-cell is influenced both by circulat- 
ing NE and NE released at nerve endings which are 
in contact with these cells  14. On the other hand, both 
in vivo and in vitro studies show that the parasympa- 
thetic neurotransmitter  acetylcholine applied to the 
pancreatic islets has the same effect as electrical stim- 
ulation of the vagus13A  6.  Because glucagon and insu- 
lin release elicited by vagal or cholinergic stimulation 
can be blocked by atropine, muscarinic receptors are 
present on the A  and B cellsS,  16. 
Though much is known about the effects of periph- 
eral manipulations of the autonomic nervous system 
on the islets of Langerhans,  our knowledge on how 
central mechanisms are involved in peripheral auton- 
omous effect is rather limited. Electrical stimulation 
of the ventromedial hypothalamic nucleus (VMH) of 
the anesthetized rat evokes a large rise of plasma glu- 
cagon  and  glucose  levels  with  a  simultaneous  de- 
crease in plasma insulin levels  9.  On  the other hand 
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electrical  stimulation  of  the  lateral  hypothalamus 
(LHA) and medial forebrain  bundle  induces an in- 
crease of plasma insulin 3. Not only electrical but also 
chemical stimulation of VMH and LHA can change 
hormone release from the pancreatic islets. Injection 
of 0.1/~g of NE bilaterally in the VMH of freely mov- 
ing rats results in a glucagon and insulin peak which 
lasts for 3 min  s. On the other hand injection of 0.1 fig 
of NE into the LHA causes an immediate insulin se- 
cretion  without  concomitant  glucagon  release  s. 
Comparable results  were  reported  by Shimazu  and 
Ishikawa25 in unrestrained rabbits. 
Not  only  experimental  stimulation  of the  VMH 
and LHA causes glucagon and insulin release, spon- 
taneous food intake also elicits an early cephalic insu- 
lin response (EIR) that starts in the first minute after 
the onset of food intake and precedes any change in 
blood nutrient  levels caused  by the  newly  ingested 
food  3°. This EIR appears to be a similar phenomenon 
as the insulin release elicited by NE injection into the 
LHA since  during  feeding  an  efflux of NE  can  be 
measured for 60-90 rain in hypothalamus and preop- 
tic area of rats starting  immediately after meal on- 
set  21. Regarding the pathway between the hypothala- 
mus and the islet of Langerhans both a neural and a 
humorai system should be taken into consideration. 
Humoral factors isolated from the hypothalamus are 
demonstrated to elicit insulin release in vitro and in 
vivo  22.  The  existence  of a  neural  pathway  follows 
from the observation that atropinization of rats sup- 
presses the EIR  30. 
Since plasma insulin, glucagon and blood glucose 
levels were studied only after a pulse injection of NE 
into the LHA the purpose of this study was to investi- 
gate those levels during infusions of small amounts of 
NE into the LHA during 20 min in order to study the 
effects  of  prolonged  increase  of  NE  levels  in  the 
LHA. As a pronounced rise of insulin was found dur- 
ing NE infusion it was investigated if this increase of 
insulin could be suppressed by muscarinic antagonis- 
tic agents like atropine. Since eating causes EIRs and 
concomitant secretion of NE in the hypothalamus the 
influence of increased NE levels in the hypothalamus 
on above-mentioned blood parameters after an oral 
and i.v.  glucose tolerance test (OGTT and 1VGTT, 
respectively) was studied.  We further studied the in- 
fluence of atropinization of the rats on the effects of 
an  OGTT and  IVGT-I" during  NE  infusion  in  the 
LHA. 
MATERIALS AND METHODS 
Subjects and maintenance 
The animals in  all experiments were male Wistar 
rats ranging in weight between 250 and 400 g at the 
beginning of the experiments. They were kept in in- 
dividual plexiglass cages (25  x  25  x  30 cm) at room 
temperature (20 °C + 2 °C) and had continuous access 
to  food  and  water,  unless  otherwise  stated.  They 
were  maintained  on  a  12-h  light-dark  cycle 
(06.00-18.00 h light). The standard C-rich diet (Mura- 
con Lab chow) contained 20% protein, 53,5% carbo- 
hydrate,  4.5%  fat and  22%  water with  added  vita- 
mins and  minerals  (4.1  kcal/g).  The rats were han- 
dled and weighed every morning at about 09.00 h. 
Surgery and control of body weight 
All surgery was performed under ether anesthesia. 
A  1-2  week  recovery period  was  allowed  between 
subsequent  surgeries.  The  experiments  started  as 
soon  as  the  rats  returned  to  pre-operative weight. 
There were no significant differences in body weight 
of the rats at the beginning of an experiment. 
Implantation of brain cannulas 
Permanent  stainless-steel  cannulas  (length  22.0 
ram, o.d. 0.3 mm, i.d. 0.1  mm) for chemical stimula- 
tion were stereotactically implanted bilaterally in the 
LHA according to he coordinates of de Groot (AP + 
5.4, V--2.3,  L  +  1.7  ram)  7.  A  sterile stainless-steel 
obturator (length  23  mm, o.d.  0.08  mm) flush with 
the tip of the cannula was used between experiments 
to ensure that the cannula remained open and pyro- 
gen free. The cannula was protected with a 21-gauge 
needle except for the last 4 mm at the top of the can- 
nula.  The protective sleeve was affixed to the  skull 
with acrylic.  Sterile polyethylene tubing  (length 7.0 
mm, o.d. 0.61 mm, i.d. 0.20 mm) was put around the 
cannula  and  obturator.  A  polyethylene cap (length 
6.0 ram) was placed at the protruding end of the 21- 
gauge needle to cover the free end of the cannula. 
Implantation of heart catheters 
All  animals  were  provided  with  a  heart  catheter 
according to the techniques earlier described  28. This 
method allows blood sampling in unanesthetized, un- 
disturbed,  free  moving  rats27.  Whenever  i.v.  infu- 
sions were performed, the rats were provided with a second heart catheter implanted in the contralateral 
(left) jugular vein. This smaller second catheter (o.d. 
0.64 mm, i.d. 0.28 mm) permits blood flow from the 
acromiodeltoid cephalic and anterior jugular vein to 
the  external  jugular  vein.  In  general,  rats  did  not 
loose weight after implantation of the second cathe- 
ter indicating that no serious blockade in venous re- 
turn from the head occurred after surgery. 
Blood sampling procedures 
All experiments were performed between 11.00 h 
and 14.00 h, i.e. during the rats light cycle. Food was 
removed 2 h before the start of an experiment. Blood 
samples of 0.06 (glucose only) and 0.3 ml were taken 
for determination  of blqod  glucose,  plasma insulin 
and glucagon. The sampling schedule is stated sepa- 
rately for each experiment. A  transfusion of citrated 
blood obtained by means of a heart puncture from a 
donor rat was given after each 0.3 ml sample unless 
otherwise stated. 
LHA infusion procedure 
After removal of the cap and the obturator, a ster- 
ile polyethylene tube (length 400 mm, o.d. 0.61 mm, 
i.d.  0.20  mm) was connected to each cannula.  The 
tube was filled with sterile test fluid except the last 8 
mm at one of the ends of the cannula which remained 
filled with air. This end of the tube was sealed off to 
prevent any unwanted leakage into the brain. Under 
the sealed end remained an air bubble with a length 
of 4 mm. After attachment of the cannulas the ani- 
mals were returned to their cages 30 min prior to the 
start of the experiments. The far end of all tubing re- 
mained outside of the cage so as not to disturb the an- 
imal27. At the start of the infusion, the sealed ends of 
the tubes were cut off and the tubing was quickly con- 
nected to the infusion pump. The infusion schedule is 
stated separately for each experiment and the start of 
moving of the air bubble was designated as time 0. 
The duration of all LHA infusions was for a 20 min 
period (0.25 #l/min). Constant moving of the air bub- 
ble originally under  the  sealed end of the  tube en- 
sured for a uniform infusion rate. 
Norepinephrine  (NE) solutions were diluted  with 
sterile saline from a stock solution of 2 mg/ml solvent 
immediately before the start of the experiment. One 
criterion  for  satisfactory  implantation  in  the  LHA 
was the occurrence of an immediate rise of plasma in- 
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sulin one minute after the start of an NE infusion. 
Chemical determinations 
The blood samples were transferred immediately 
to  chilled  (0 °C)  centrifuge  tubes,  containing  5  /~1 
heparin solution (500 U/ml) as anticoagulant and 5/~1 
aprotinin  solution  (120  klU//~l,  NOVO)  to prevent 
proteolysis of glucagon. 
Blood  glucose was measured  by the  ferricyanide 
method  of Hoffman (Technicon  Autoanalyzer TM 
II) with 0.05 ml blood taken from the 0.3 ml sample. 
The remaining 0.25 ml blood was centrifuged at 4 °C 
and the supernatant  stored at --30 °C.  Rat specific 
plasma immunoreactive insulin (IRI) and plasma im- 
munoreactive glucagon  (IRG) were  determined  by 
means of a radioimmunoassay kit (NOVO).  Guinea 
pig serum M8309 served as antiserum for the insulin 
assay. Antiserum K964 was used for the glucagon as- 
say and has very little cross-reaction with gut gluca- 
gon. Duplicate assays were performed on 25/~1 plas- 
ma samples.  Both in the insulin and glucagon assay 
the  bound  and  free125I-labeled hormone  was  sepa- 
rated  by  means  of  a  polyethylene-glycol  solution 
(23.75% w/w) as suggested by Henquin et al. n. 
Histology 
Cannula  placement  was  investigated.  The  rats 
were anesthetized with ether and perfused with 10% 
formalin. The brains were removed and stored over- 
night  in  10%  formalin and 4%  glucose.  The brains 
were frozen quickly in melting isopentane (--80 °C) 
and cut at 40/~m on a cryostat microtome. Brain slices 
were stained with cresyl fast violet, examined under a 
light microscope and compared with the atlas of De 
Groot  7. Only the results of rats with correct cannula 
placements were used. 
Infusion of NE in the LHA 
The purpose of this experiment was to investigate 
the plasma insulin, glucagon and blood glucose levels 
during  infusions  of different quantities  of NE (at a 
rate of 6.25, 12.5 and 25 ng/min) in the LHA. At the 
most appropriate dose the NE infusion was adminis- 
tered in the absence and presence of atropine. 
Two groups of rats were used. Group 1: rats (n =  7) 
with  an  initial  mean  weight  of 250  g  randomly re- 
ceived 4 treatments, i.e. 3 doses of NE or a NE-sol- 
vent solution. NE was administered at a low (6.25), 354 
medium  (12.5),  or high,  25.0 ng/cannula/min dose. 
The NE or its vehicle was given over a 20 min period, 
total volume infused was 5/,tl at a rate of 0.25/,d/min. 
Each rat received each of the 3 doses but once with 
an interval of at  least  2 days in  between.  Group 2; 
rats (n = 6) with a mean weight of 400 g, at the begin- 
ning of the experiment, randomly received two treat- 
ments,  i.e.  a  NE-infusion  12.5  ng/cannula/min with 
or without atropinesulfate (0.5 mg/kg). The atropine 
pulse was administered via the heart catheter 10 min 
prior to the NE-infusion. Blood transfusions of 1.2 ml 
were given at t = --11, +9 rain, and after the comple- 
tion of the  experiment.  An interval  of at  least  two 
days  was  allowed  between  treatments.  The  blood 
sampling procedure for both  groups was t  =  --11, 
---6 (blood glucose only)--1, +1,  +3,  +5,  +7,  +9, 
+14, +19, +24 and +34 rain.  NE infusions started at 
time point 0. 
An oral glucose tolerance test during NE infusion in 
the LHA 
In the previous experiment we observed that NE 
infusion in the LHA resulted in a significant increase 
of plasma insulin.  The aim of this experiment was to 
determine whether or not there was any interaction 
between glucose-stimulated insulin  release  and NE- 
stimulated  insulin  release.  In  this  experiment  rats 
provided  with  LHA cannulas  and  a  heart  catheter 
were infused with NE at a rate of 12.5 ng/min/cannu- 
la.  During this infusion rats received an oral glucose 
tolerance test (OGTI') of 135 mg glucose dissolved in 
1.5 ml of water. 
Seven rats with a mean body weight of 300 g at the 
beginning of the experiment were used for the oral 
glucose tolerance test.  Blood samples were taken at 
t = --11, --1 (start infusion in the LHA was at time 0), 
+1, +3, +5 (start of OGTI" was at time 5),  +6, +8, 
+10, +12, +17, +22, +32 and +42 min. Blood trans- 
fusions were given at t = --11, +8 and after the com- 
pletion of the experiment. One week prior to the ex- 
periment, the rats were conditioned to lick 1.5 ml of a 
9% glucose solution (135 mg). The freshly prepared 
glucose solution was offered in a porcelain dish. Five 
minutes  before the  presentation  of the  glucose the 
NE  infusion  was  begun.  All  animals  received  an 
OGqT. Each rat was given randomly glucose +  buf- 
fer infusion, or glucose +  NE infusion in the LHA. 
An intravenous glucose tolerance test during NE infu- 
sion in the LHA 
In the previous experiment it was clearly demon- 
strated that an OGTT during NE infusion in the LHA 
elicited an exaggerated insulin release. The question 
arises as to the cause of this exaggerated insulin re- 
lease.  It can be hypothesized that stimulation of re- 
ceptors  in  the  oral  cavity  by  glucose  strongly  en- 
hances  the  effects  of  the  already  NE  stimulated 
LHA. It might also be hypothesized that an increased 
sensitivity of the B cell of the islet of Langerhans to a 
certain glucose load is responsible for the observed 
phenomenon. To discern between  both possibilities 
rats were subjected to an  i.v.  glucose tolerance test 
(IVGTT) during either  NE infusion  or buffer infu- 
sion in  the LHA.  If the exaggerated insulin  release 
during NE infusion in  the LHA is caused by an in- 
creased sensitivity of the B cells to a certain oral glu- 
cose load a similar phenomenon must occur during an 
IVGTT, 
In  this  experiment  a  new  group of 7  rats  (mean 
weight 300 g) provided with LHA cannulas and two 
heart catheters (one for the withdrawal of blood and 
the other smaller one for the  infusion of fluids) re- 
ceived infusions in the LHA with either NE at a rate 
of 12.5 ng/min/cannula or buffer. During this infusion 
rats  were  subject  to  an  i.v.  glucose  tolerance  test 
(IVGTlr). An i.v. glucose load of 80 mg glucose, dis- 
solved in 1.5 ml of saline was administered at a rate of 
0.1 ml/min via the smaller of the two catheters,  This 
glucose load was chosen because this load leads to a 
moderate  increase  of both  glucose and  insulin  lev- 
els  29. 
The infusion tube was filled with the glucose solu- 
tion except for the last 2 cm which were filled with sa- 
line.  The glucose solution and saline were separated 
by a small  air bubble (1 mm). Disappearance of the 
small air bubble in the needle attached to the skull of 
the rat which took only 5 s after the start of the infu- 
sion was termed as the start of the IVGTT. Five min- 
utes before the start of the IVGTT the NE infusion 
was begun. All animals received an IVGTT. Each rat 
was given randomly i.v.  glucose +  buffer infusion in 
the LHA, or i.v.  glucose +  NE infusion in the LHA. 
Blood samples were taken at --11, --1 (start infusion 
in LHA was at time 0), +1, +3, +5 (start of IVGTI" 
was at time +5),  +6, +8, +10, +12, +17, +22, +32 
and +42 min. Effects  of atropinization  on an  OGTT and  IVGTT 
during NE infusion in the LHA 
In the previous experiments it was clearly demon- 
strated that insulin  release was strongly augmented 
during both an OGTI" and an IVGTT by a simulta- 
neous  infusion  of NE  in  the  LHA.  The  question 
arises as to which pathway is involved regarding this 
potentiation of insulin release. Humoral factors can 
be released by the hypothalamus during noradrener- 
gic stimulation of the LHAn. On the other hand, it is 
most likely that neural pathways are involved in the 
observed phenomenon. In this respect the dorsal mo- 
tor vagus nucleus  and its efferent fibers are promi- 
nent relays since vagal stimulation elicits insulin  re- 
lease6jS, 17 and the suppression of insulin  release by 
atropinization  during  noradrenergic  stimulation  of 
the LHA as described above leads to the same con- 
clusion.  For  that  reason  the  following  experiment 
was performed in which  an OGTT and  an  IVGTI" 
was given to rats during NE infusion in the LHA with 
and without atropine administration prior to the NE 
infusion. 
A  group  of 9  rats  were  used  in  this  experiment 
(7  out  of the previous experiment and 2  additional 
ones). The effect of atropine was tested in these ani- 
mals.  The  rats  randomly  received  two  treatments, 
i.e.  an NE infusion  of 12,5  ng/cannula/min  with  or 
without  atropine  sulfate  (0.5  mg/kg).  An  atropine 
pulse was administered via the heart catheter 10 min 
prior to the NE infusion in the LHA which was given 
during a period of 20 min. In the control situation a 
saline injection was given via the heart catheter in- 
stead of an atropine pulse. Five minutes after the start 
of NE infusion the OGTI" was started. Blood samples 
were taken as in the OGTT and IVGTT exeriments, 
however, 10 and 1 min before atropine injection two 
additional  blood samples were taken.  It was meas- 
ured that the rats were eating the glucose at the same 
speed after atropinization as in the situation without 
atropinization.  All  animals  finished  their  glucose 
meal within 1 min. In addition in the same rats com- 
parable experiments were performed but instead of 
an OGTI" they received an IVGTI'. 
RESULTS 
Infusion of NE into the LHA 
The results of the parametric study are presented 
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Fig. 1. Effect of infusion of different doses of NE in the LHA on 
blood glucose and plasma insulin. Data are expressed as means 
+ S.E. mg/dl and/zU/ml respectively, changes from preinfusion 
levels of glucose and insulin which were the average of time 
points --11 and --1 min levels. 
in Fig.  1. Average basal insulin level, i.e. before the 
start of NE infusion in the LHA was 20 +  4.3/~U/ml 
plasma. Analysis of variance applied to these means 
revealed  significant  differences  among the  4  treat- 
ments (F (3.35) P <  0.01). All 3 doses of NE resulted 
in a significant rise in plasma insulin levels within the 
first minute when compared to the infusion of the ve- 
hicle  alone  and  remained  elevated during  the  infu- 
sion with the exception of the low dose. The insulin 
levels remained elevated during infusion of the high 
dose  (25.0  ng/min)  and  middle  dose  (12.5  ng/min) 
and  differences between  these  two doses regarding 
insulin levels could not be measured. No significant 
changes  in  blood  glucose  levels were  observed  al- 
though a slight increase was noted when NE was in- 
fused at all 3 doses. 
As shown in Fig. 2, atropine completely inhibited 
the NE stimulated  insulin  response  within  the  first 
minute  and  continued  to  suppress  this  response 
throughout the experiment with mean insulin levels 
returning to pre-infusion levels at --34 min.  In this 
group of rats insulin levels i.e before the start of NE 
infusion in the LHA was 45  _+ 6.8 pU/ml plasma in 
the nonatropinized group and 39 +  5.3 in the atropi- 
nized  group.  No  significant  differences  were  ob- 
served between  the  two treatment groups in  either 
plasma glucagon or blood glucose levels. 356 
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Fig. 2. Effect of NE infusion in the LHA (12.5 ng/min at rate of 
0.25 ~l/min during 20 rain) on blood glucose, plasma insulin and 
glucagon  either with  atropinization (0.5  mg/kg),  O----O, or 
without  atropinization,  0-----0.  Data  are  expressed  as 
means +  S.E. mg/dl, pU/ml, pg/ml respectively, changes from 
preatropinization levels of glucose, insulin and glucagon which 
were the average of those of time point 1 min before atropiniza- 
tion. 
An oral glucose tolerance  test during NE infusion in 
the LHA 
Ingestion of glucose (135 mg) elicited an early in- 
sulin response (EIR) in both treatment groups eating 
glucose and receiving either NE or buffer solution in 
the  LHA.  However,  a  much  greater  response  was 
measured in the rats eating glucose during infusion of 
NE  in  the  LHA  (Fig. 3).  Mean  change  in  the  first 
minute  compared  to  baseline  insulin  levels for  the 
two experimental situations were oral glucose +  NE 
in the LHA 79 +  20.8pU/ml; oral glucose +  buffer in 
the LHA 13 +  8.9~U (P <  0.02 Student's t-test). Prior 
to glucose ingestion NE  infusion  into  the  LHA  re- 
sulted in an immediate rise in insulin within the first 
minute (mean change from baseline 45 +  5.4/~U/ml). 
Four minutes later, i.e.  1 rain before the start of the 
OGTI', the  mean  change  above baseline was  15  + 
9.3pU/ml. 
Oral glucose elicited a  small increase in glucagon 
levels within  the first minute  for the  two  treatment 
groups.  Mean  change in glucagon levels in the first 
minute for the treatments were: oral glucose +  NE in 
the LHA 51  __+  26.0 pg/ml; oral glucose  +  buffer in 
the LHA 85  +  21.3 pg/ml. No reliable difference in 
glucagon levels was  observed among the  two  treat- 
ment groups prior to the ingestion of glucose. A  small 
nonsignificant rise in glucose was measured 3  and 5 
min after the start of NE infusion in the LHA as com- 
pared  to  the  situation  with  buffer  infusion  in  the 
LHA: (third min 9 +  3.1 mg/dl vs 2 +  3.9 ml/di, fifth 
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Fig. 3. Mean changes + S.E. of blood glucose (mg/dl), plasma 
insulin (~U/ml) and plasma glucagon (pg/ml) during ingestion 
of 135 mg glucose which was ingested during either buffer infu- 
sion  at a  rate of 0.25/~l/min  during 20  rain,  O---C), or NE 
infusion in the LHA (12.5 ng/min at a rate of 0.25/~l/min during 
20 min), 0-----0, min 11 +  2.5 mg/dl vs 2 +  3.4 mg/dl). During and af- 
ter ingestion of glucose an increment in blood glucose 
was present in both  experimental situations  and  at 
min 17  (i.e.  12 min after the start of glucose inges- 
tion) a peak value was reached of 26 +  4.2 mg/dl in 
the situation in which NE was infused in the LHA vs 
23 +  5.1 mg/dl in the situation in which buffer was in- 
fused in the LHA. Then glucose declined in both situ- 
ations in exactly the same way. 
An intravenous glucose tolerance test during NE infu- 
sion in the LHA 
The results in Fig.  4 show that infusion of buffer 
in the LHA before infusion of glucose in the general 
circulation did not lead to any changes in plasma in- 
sulin. The superimposed'glucose infusion elicited in- 
sulin  release  in  the  first minute.  Peak values were 
reached  in  the  first  and  third  minute  of 22  +  5.4 
/~U/ml and 13 +  6.3/~U/ml plasma, respectively. 
On  the  other  hand,  infusion  of NE  in  the  LHA 
caused a small increase of insulin before the IVGTI'. 
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Fig. 4. Mean changes +  S.E. of blood glucose (mgldl) and plas- 
ma insulin (~Ulml) during i.v. infusion of 80 mg glucose, which 
was infused during either buffer infusion at a rate of 0.25/A/min 
during  20  min,  (3----<D, or  NE  infusion  in  the  LHA  (12.5 
ng/min at a rate of 0.25/A/min during 20 min), O----O. 
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The IVGTT elicited a peak in insulin release reach- 
ing 62 +  15.8/~U/ml in the first minute and 30 +  5.0 
/~U/ml plasma in the third minute. The observed dif- 
ference between the two treatments in the first and 
third  minute  after glucose  infusion  are  statistically 
significant (P <  0.05 and P  <  0.05 respectively, Stu- 
dent's t-test). After the first peak a second peak fol- 
lowed which was much larger during NE infusion in 
the LHA than during buffer infusion in the LHA. 
Regarding blood glucose, virtually no differences 
could be observed before the IVGTT and also during 
the first and third minute of the IVGTT only minimal 
differences were found in blood glucose: in the first 
minute  an increase  of 13  mg/dl with NE treatment 
and 13 mg/ml with buffer treatment; and in the third 
minute 23 mg/dl and 22 mg/dl respectively. After this 
initial simultaneous rise, blood glucose reached high- 
er values in the NE treatment than in the buffer treat- 
ment situation. In the seventeenth min after the start 
of  the  IVGTT the  concentrations  were  48  +  2.3 
mg/dl and 31 +  3.6 mg/dl respectively. 
Effects of atropinization  on  an  OGTT and IVGTT 
during NE infusion in the LHA 
As depicted in Fig.  5 in the 9 animals insulin rose in 
the first and third minute of the OGTr during NE in- 
fusion in the LHA and without atropinization 49  + 
11.8/~U/ml and 37  +  8.6 k~U/ml plasma above base- 
line respectively. The insulin rise with atropinization 
was at the same time points 5 +  2/~U/ml and 6 +  1.7 
/~U/ml plasma respectively. These  differences were 
statistically significant; in the first min P  <  0.005, in 
the third min P <  0.005. Also after the third minute a 
considerable suppression of insulin release could be 
observed in the atropinized rats.  Prior to glucose in- 
gestion NE infusion in the LHA resulted in a rise in 
insulin which was smaller after atropine administra- 
tion just as described above (cf. Fig.  2). 
Regarding  glucose,  an  immediate  rise  was  ob- 
served With NE infusion in the LHA +  an OGTT + 
atropine  treatment  after  the  start  of NE  infusion. 
Glucose reached its zenith of 29  +  2.7 mg/dl above 
baseline level in the seventeenth min in this situation. 
Without  atropine,  however,  glucose  started  to rise 
only after the beginning of glucose ingestion,  a  ze- 
nith was reached of 26  +  2.9  mg/dl above baseline 
level in  the  seventeenth  minute.  Atropinization  of 
the rats caused a significant increase of glucose in the 358 
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first, third,  fifth, sixth and eighth min after the start 
of NE infusion in the LHA. 
As Fig.  5 shows, atropinization  of the rats before 
infusion of NE in the LHA and an IVGTT resulted in 
a considerable suppression of insulin during the first 
min after the start of the IVGTT: 62  _+  15.8 ~U/ml 
without atropinization vs 17 +  3.2~U/ml plasma with 
atropinization  (P <  0.02  Student's  t-test).  Thereaf- 
ter, insulin levels did not differ significantly in the sit- 
uation with atropinization  as compared to that with- 
out atropinization.  After an initial comparable level 
in both situations glucose rose much more after the 
first rain of the 1VGTF with atropinization.  Glucose 
reached a zenith in the 12th min of the IVGTT: 72 + 
5.5 mg/dl above baseline level with atropinization vs 
47  +  4.7  mg/dl  blood  without  atropinization  P  < 
0.005 (Student's t-test). 
DISCUSSION 
The results of these experiments indicate that nor- 
adrenergic stimulation of the LHA causes insulin re- 
lease  and  that  cholinergic pathways are  involved in 
the mediation of these chemically applied stimuli. 
In the parametric study (experiment  1) and subse- 
quent replications  (experiment  2, 3 and 4) NE infu- 
sions over a 20 min period elicited an insulin response 
within the first minute. This immediate rise in insulin 
was observed in the 6.25 (low) as well as in the 12.5 
(middle)  and 25.0 ng/min (high) dose in addition to 
the 5 replications using the NE dose of choice,  12.5 
ng/min. 
These data are in agreement with studies in which 
it is reported that injections of NE into the hypothal- 
amus,  both the LHA and VMH elicit an insulin  re- sponse  within  the  first  minute  8.  Although  the  NE 
stimulatory effect on insulin was highly significant, the 
magnitude of the increase of insulin levels within the 
first minute was not as large as reported previouslyS. 
A  Insulin  =  62  in  that  study  vs 28  reported  here. 
However, in the earlier study  8, NE was injected as a 
pulse  (0.1  /~g/#l),  whereas  in  the  present  investiga- 
tion NE was applied over 20 min at 12.5 ng/min (total 
0.25 pg/5/A). Both the dilution factor and the rate at 
which the NE was administered may have accounted 
for the lower curves in our study. 
Another  point  merits  attention  here.  Infusion of 
12.5 ng/min during 20 min elicited a larger insulin re- 
sponse in the rats participating in the NE infusion in 
the  LHA  experiment  with  atropinization  than  in 
those participating in the experiment in which several 
doses  of  NE  were  administered  in  the  LHA  (cf. 
Figs.  1 and 2). This may be due to the difference in 
body weight of both groups of rats. Also, the basal in- 
sulin  level was higher  in  the group of heavier rats. 
This  is  in  agreement  with  the  idea  of  Porte  and 
Woods 1 who  reported  firstly a  correlation  between 
basal insulin levels and body weight both in man and 
rats and secondly that the increase of insulin after an 
insulinogenic stimulus is proportional to the basal in- 
sulin level. 
In spite of the higher insulin levels during NE infu- 
sion in the LHA no change in glucose levels could be 
observed though a decline should be expected. Prob- 
ably counterregulatory mechanisms prevent such an 
expected decline. The nature of these mechanisms is 
not  clear  as  yet.  As  glucagon  does  not  rise  an  in- 
creased  sympathetic tone  which  augments  the  glu- 
cose output from the liver20,24 is less probable. More- 
over,  an  increase  in  insulin  level would  not  be ex- 
pected with increased sympathetic tone. Most likely 
candidates for this counterregulation are growth hor- 
mone  and  adrenal  cortical  hormones  released  via 
ACTH.  Also changes in  insulin  receptor sensitivity 
cannot be excluded. This needs further elucidation. 
Atropine  sulphate  suppressed  insulin  release  by 
NE infusion in the LHA. This finding suggests that 
the vagal nerve is involved in the release of insulin af- 
ter NE  stimulation  of the  LHA and  that  the  vagal 
nerve takes part in the efferent circuit between the 
LHA and the  islets  of Langerhans  (experiment  1). 
One  problem  may  arise:  in  the  presented  experi- 
ments atropine sulphate was administered as an anti- 
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cholinergic drug. In contrast with methylatropine, at- 
ropine is able to pass the blood-brain barrier. There- 
fore it can be argued that atropine does not act on 
cholinergic  receptors of the  B  cells of the  islets  of 
Langerhans but on cholinergic pathways in the CNS 
which connect the LHA with the dorsal vagal motor 
nucleus.  However, preliminary results of a study in- 
vestigating  the  neural  circuitry  between  the  LHA 
and the motornucleus of the vagus related to insulin 
release  indicate  that  CNS  cholinergic pathways are 
unlikely to be involved in such connections (Luiten, 
unpublished results). 
Results of other studies confirm the idea of a vagal 
contribution  to  insulin  release6,10,15,17. Hyperinsuli- 
nemia induced by lesions of the ventromedial hypo- 
thalamus (VMH) could be reduced by subdiaphrag- 
matic vagotomy2,12.  Also subdiaphragmatic vagoto- 
my prevented the increased output of insulin in VMH 
lesioned rats during a glucose load administered im- 
mediately after induction  of the  lesion  3.  The  most 
conspicuous result of experiment 2 was that though 
an oral glucose challenge elicits an immediate rise in 
insulin levels within the first and third minute of an 
OGTT in the experimental rats, it was in the NE in 
the LHA +  an OGTI" group that the largest increase 
of insulin levels was observed (Fig. 3) which contin- 
ued during the whole period of NE infusion. This in- 
crease  was  significantly  different  from  the  control 
group. 
At this point it is necessary to draw attention to the 
relatively small early insulin response (EIR) elicited 
by the OGTI" in the control group which rose in the 
first minute to 13  +  8.9 pU/ml plasma (Fig.  3). This 
small increase is due to the fact that in this experi- 
ment the rats ingested a small amount of a rather di- 
luted glucose solution  (135  mg in  1.5 ml).  The cus- 
tomary  rise  in  glucose  due  to  eating  was  also  ob- 
served.  Though  the  glucose  level  was  somewhat 
higher in experiment 2 (Fig.  3) at the start of glucose 
ingestion in the situation in which NE was infused in 
the LHA as compared to the situation in which buffer 
was infused, it is unlikely that this higher basal level is 
responsible  for  the  potentiated  insulin  release  be- 
cause  a  comparable  higher  glucose  level  was  not 
found in experiment 3, in which also a potentiation of 
insulin  was  observed  albeit  during  an  IVGTT 
(Fig. 4). 
Regarding  the  insulin  response  to  an  IVGTT, it 360 
was demonstrated that NE infusion in the LHA led to 
a considerable potentiation of insulin release. During 
the first part of the IVGTT the rise of glucose was the 
same during both NE and buffer infusion in the LHA 
consequently the potentiation cannot be due to an in- 
creased glucose level. The continuation of the exag- 
gerated insulin response on the other hand in the NE 
infused rats can be partly due to an increased glucose 
level which  occurs in the  latter part of the  IVGTT 
(see Fig. 4).  The reason for the higher glucose level 
in the rats infused with NE in the LHA to that in the 
rats  infused  with  buffer might  be  attributed  to  in- 
creased  growth  hormone  and  corticosterone  levels 
which  counteract  the  peripheral  utilization  of glu- 
cose.  The  diminished  utilization  leads  to  a  rise  of 
blood  glucose  which  in  its  turn  triggers  insulin  re- 
lease.  This  supposition  needs  further  experimental 
support. 
Atropinization  of the  rats  caused  a  considerable 
suppression of insulin  during  infusion  of NE in the 
LHA and an OGTT (see Fig. 5). This suppression is 
the more noteworthy because it is accompanied by a 
concomitant higher glucose level which should stimu- 
late insulin release. In the experiment with NE infu- 
sion in the LHA and an IVGTT with atropinization 
(see Fig.  5) only in the first minutes of the IVGTI" a 
suppression of insulin could be measured. After that 
insulin rose in nearly the same extent as in the experi- 
ment without  atropinization.  This second  phase in- 
sulin  rise  might  be  explained  by  the  concomitant 
much stronger glucose rise in the experiment with at- 
ropinization. The increased augmentation of glucose 
both in the OGTf and IVGTT with atropinization as 
compared  to  the  situation  without  atropinization 
might be due to increased glucose production or to 
decreased  uptake  of the  either  ingested  or infused 
glucose in the splanchnic bed. The most obvious ex- 
planation  is  decreased  cholinergic  activation of the 
liver glycogen synthetase  system  24,26 but  this  needs 
further  experimentation.  The  much  higher  glucose 
increase  during  an  IVGTT than  during  an  OGq~ 
with  atropinization  and  during  NE  infusion  in  the 
LHA might be the result of decreased gastrointesti- 
nal  motility  and  resorption  after  atropinization  so 
that glucose does not rise as high as during i.v. infu- 
sion. 
It can be concluded that artificially increased nor- 
adrenergic activity of the LHA has a powerful effect 
on the B cell of the islet of Langerhans. McCaleb et 
al. 21 demonstrated that feeding elicits already in the 
first minute an immediate increase in norepinephrine 
release from neurons in the hypothalamus and nor- 
adrenergic bundle  in the preoptic area.  From these 
data it is an obvious assumption that the early insulin 
response which occurs at the onset of eating before 
any absorption of newly ingested nutrients is caused 
by increased noradrenergic activity of the LHA. At 
the moment our concept is that the state of the nor- 
adrenergic activity of the LHA is responsible for the 
quantity of insulin released by a glucose load, i.e. low 
noradrenergic activity of the LHA is accompanied by 
a moderate insulin secretion and high noradrenergic 
activity of the LHA by a large insulin release after a 
certain glucose load.  As appears from the results of 
this work insulin release elicited by the LHA is most 
probably  mediated  by  parasympathetic  pathways. 
That neural mechanisms are involved in an early in- 
sulin  response  as  a  result  of food  intake  has  been 
shown by Strubbe and Van Wachem  31. These authors 
demonstrated that E1Rs are completely absent in di- 
abetic  rats  recovered  by islet  of Langerhans  trans- 
plants  which  have  no  innervation,  although  blood 
glucose and plasma insulin profiles are normal in the 
intermeal periods. However, results of recent papers 
indicate that besides neural factors also humoral fac- 
tors released by the hypothalamus might play a role 
in insulin secretion3,22.  The reason of the coexistence 
of both a neural and a neurohumoral system that con- 
trol insulin release needs further elucidation. 
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